18038-1-AP

antibody from Proteintech Group

Targeting: SMURF2

ELISA (Data presented on provider website)

Antibody Data

Product number

18038-1-AP

Provider

Proteintech Group

Product name

SMURF2 antibody

Antibody type

Polyclonal

Description

SMURF2 antibody (Cat. #18038-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

SMURF1 Regulates CTCF-HOXA10 Axis and Promotes Tumor Progression in Nasopharyngeal Carcinoma.

Jin Y, Zhang T, Wu Z, Liang Y, Jiang Y, Yu G
Cancer science 2026 May;117(5):1346-1361

---

Neddylation Targets and Stabilizes NLRP3 to Augment Inflammasome-Mediated Colitis and Mood Disorder.

Gai W, Wu M, Wu A, Jing Z, Ye Z, Jin J, Zhang Y, Zhao M, Liu G, Wang X, Yang X, Dong J, Xu Y, Zhang J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Mar;13(16):e05906

---

SMURF1 Downregulation Highlights Its Potential Role in Breast Cancer.

Tekin L, Dinç F, Yazkan C, Cenik M, Özdemir Ç, Amaç O, Edgünlü T
International journal of molecular sciences 2026 Feb 17;27(4)

---

FOXA2/miR-148a-3p/SMURF2 signaling feed-forward loop alleviates spinal cord ischemia-reperfusion injury-induced neuropathic pain by modulating microglia polarization in rats.

Hao X, Cao L, Li J, Lei Q, Liu X, Li Y, Fan Y, Xu J, Fang B
Frontiers in immunology 2025;16:1563377

---

Targeting Intratumoral Copper Inhibits Tumor Progression via p62-Mediated EZH2 Degradation and Potentiates Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinoma.

Lin X, Chen W, Li B, Zhao Z, Yu Z, Zhao XY, Zhou X, Feng Z, Lin C, Cao W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Oct;12(40):e17795

---

SMURF2 inhibition attenuates cardiac hypertrophy through blocking ubiquitination degradation of AXIN1.

Kang Y, Zu Y, Fan QY, Liu XM, Chen SQ, Ruan LL, Tang X, Xie LP, Ji Y
Acta pharmacologica Sinica 2025 Nov;46(11):2951-2962

---

IL-17C-Mediated Upregulation of SMURF2 Induces Psoriatic Changes in Keratinocytes by Facilitating PPP6C Ubiquitination.

Mao J, Ma X, Sun Y, Wang W, Li B
Cell biology international 2025 Jul;49(7):798-809

---

SMURF2 Inhibits Autophagy and Growth in Ovarian Cancer by Regulating the RACK1/AKT/mTOR Pathway.

Wu L, Xiao Z, Zhang S, Guo L, Liu X, Zhang L, Xu J, Lv M, Wang J
American journal of reproductive immunology (New York, N.Y. : 1989) 2025 Aug;94(2):e70140

---

UBE2C promotes pancreatic tumorigenesis by KRAS stabilization via APC/C(CDH1)-mediated WDR76 degradation.

Wang L, Chen X, Qu R, Shao S, Gong L, Li T, Jiang S, Lu Y, Ma Y, Sun Y, Cui D, Xiong X, Zhao Y
Cancer letters 2025 Aug 30;633:218013

---

UPF1 Alleviates Myocardial Ischemia-Reperfusion Injury by Regulating SMURF2-Mediated Ubiquitination Degradation of FOXA2.

Li A, Li P, Mu C, Li D, Chen K, Liang Z
Korean circulation journal 2025 Apr;55(4):305-321

---

SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation.

Zhang W, Dai J, Hou G, Liu H, Zheng S, Wang X, Lin Q, Zhang Y, Lu M, Gong Y, Xiang Z, Yu Y, Hu Y
Molecular cell 2023 Dec 7;83(23):4352-4369.e8

---

Acid ceramidase targeting pyruvate kinase affected trypsinogen activation in acute pancreatitis.

Xiao J, Zeng W, Zhang P, Zhou Y, Fang Q
Molecular medicine (Cambridge, Mass.) 2022 Sep 6;28(1):106